The estimated Net Worth of Lorenz Muller is at least $157 Тысяча dollars as of 26 August 2020. Mr Muller owns over 5,700 units of Milestone Pharmaceuticals Inc stock worth over $157,160 and over the last 5 years he sold MIST stock worth over $0.
Mr has made over 2 trades of the Milestone Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 5,700 units of MIST stock worth $8,778 on 26 August 2020.
The largest trade he's ever made was exercising 53,071 units of Milestone Pharmaceuticals Inc stock on 1 October 2019 worth over $81,729. On average, Mr trades about 9,795 units every 55 days since 2019. As of 26 August 2020 he still owns at least 108,386 units of Milestone Pharmaceuticals Inc stock.
You can see the complete history of Mr Muller stock trades at the bottom of the page.
Lorenz Muller is the Chief Commercial Officer at Milestone Pharmaceuticals Inc.
Mr Muller is 57, he's been the Chief Commercial Officer of Milestone Pharmaceuticals Inc since . There are 3 older and 2 younger executives at Milestone Pharmaceuticals Inc. The oldest executive at Milestone Pharmaceuticals Inc is Dr. Philip T. Sager FACC, FAHA, FHRS, M.D., 65, who is the Chief Medical Advisor & Member of the Scientific Advisory Board.
Lorenz's mailing address filed with the SEC is C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTR?AL, A8, H4M 2X6.
Over the last 5 years, insiders at Milestone Pharmaceuticals Inc have traded over $8,160,062 worth of Milestone Pharmaceuticals Inc stock and bought 3,714,592 units worth $46,347,389 . The most active insiders traders include Holdings A/S Novo, Investments, Lpwong Roderic... и Joseph C Papa. On average, Milestone Pharmaceuticals Inc executives and independent directors trade stock every 57 days with the average trade being worth of $438,690. The most recent stock trade was executed by David Bharucha on 1 December 2022, trading 10,000 units of MIST stock currently worth $47,400.
milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.
Milestone Pharmaceuticals Inc executives and other stock owners filed with the SEC include: